FundamentalVR secures Series B growth investments to disrupt the medical simulation market – expected to be worth $4.2 billion by 2025.

CMR Surgical has produced Versius Virtual Reality in partnership with FundamentalVR, a leading virtual reality education platform, and will continue to develop the programme in collaboration with surgical teams.

FundamentalVR debuts further capabilities to accelerate the adoption of endovascular products and procedures

CMR Surgical has produced Versius Virtual Reality in partnership with FundamentalVR, a leading virtual reality education platform, and will continue to develop the programme in collaboration with surgical teams.

CMR Surgical has produced Versius Virtual Reality in partnership with FundamentalVR, a leading virtual reality education platform, and will continue to develop the programme in collaboration with surgical teams.

Today, VR is being used in ophthalmology to enhance training and education around the world and offers multiple physical and cognitive benefits to the users. By combining VR with cutting edge haptic technology, which provides surgeons with the ability to both see and feel a virtual patient, surgeons can train and gain ‘pre human’ competence within a range of ophthalmic surgeries, devices and therapies.